SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA issues EIR with VAI classification to Solara Active Pharma Sciences’ Puducherry facility

29 Apr 2026 Evaluate

US Food and Drug Administration (USFDA) has concluded inspection at Solara Active Pharma Sciences’ Ibuprofen manufacturing facility at Puducherry. USFDA has issued an EIR (Establishment Inspection Report) on April 24, 2026 with inspection classification of the facility as ‘Voluntary Action Indicated (VAI)’ and concluded this inspection as ‘Closed’.

The unannounced inspection was carried out by the US Food and Drug Administration between February 02, 2026 to February 6, 2026. 

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

498.60 9.05 (1.85%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.20
Dr. Reddys Lab 1322.95
Cipla 1309.90
Zydus Lifesciences 891.65
Lupin 2303.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×